Trial: MTX-071-P02
Lopain (MTX-071 / resiniferatoxin)
Title | Description |
|---|---|
| Trial ID | MTX-071-P02 |
| Compound | Lopain (MTX-071 / resiniferatoxin) |
| Trials sponsor | |
| Trial phase | |
| Brief title | An open label, single dose phase Ib/IIa study to determine the safety and clinical effects of intra-articular injections of low doses of Lopain (MTX-071) in patients with chronic osteoarthritic knee joint pain |
| Indication | Osteoarthritis |
| UTN | |
| CTG ID | |
| CTIS ID (former EudraCT) | |
| Trial status | Completed |
| FPI | |
| LPO | |
| Countries | |
| Gender | |
| Age | |
| Results | No |
| Pubmed | |
| Documents |